Media Release
Novartis commends publication of major report which recommends broad use of dual bronchodilators to treat COPD
2017 GOLD report recommends the first-line use of dual bronchodilators, such as indacaterol/glycopyrronium bromide, in the treatment of the majority of symptomatic COPD patients
Bronchodilation…